{"canonical":"https://abierto.us/vendors/glyphic-biotechnologies-inc-f57wt7jzdh19","key":"F57WT7JZDH19","name":"GLYPHIC BIOTECHNOLOGIES, INC.","uei":"F57WT7JZDH19","city":"NEW YORK","state":"NY","awards":1,"obligated":"249993.28","notices_won":0,"top_agency_name":"Defense Health Agency","top_naics":"541715","cage":"94M19","parent_name":"GLYPHIC BIOTECHNOLOGIES, INC.","also_known_as":[],"country":"USA","actions":1,"first_action":"2024-04-08","last_action":"2024-04-08","breakdowns":{"naics":[{"key":"541715","name":null,"awards":1,"obligated":"249993.28"}],"places":[{"key":"NY","name":null,"awards":1,"obligated":"249993.28"}],"agencies":[{"key":"97DH","name":"Defense Health Agency","awards":1,"obligated":"249993.28"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":1,"obligated":"249993.28"}],"award_types":[{"key":"PURCHASE ORDER","name":null,"awards":1,"obligated":"249993.28"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":1,"obligated":"249993.28"}],"product_service_codes":[{"key":"AN11","name":null,"awards":1,"obligated":"249993.28"}]},"awards_list":[{"award_key":"CONT_AWD_HT942524P0042_9700_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_HT942524P0042_9700_-NONE-_-NONE-/","piid":"HT942524P0042","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"F57WT7JZDH19","recipient_name":"GLYPHIC BIOTECHNOLOGIES, INC.","recipient_uei":"F57WT7JZDH19","recipient_cage":"94M19","recipient_city":"NEW YORK","recipient_state":"NY","sub_name":"Defense Health Agency","office_name":"ARMY MED RES ACQ ACTIVITY","office_key":"o-HT9425","first_action_date":"2024-04-08","last_action_date":"2024-04-08","actions":1,"obligated":"249993.28","current_total_value":"249993.28","potential_total_value":"249993.28","naics":"541715","psc":"AN11","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":2,"description":"MEDICAL R AND D PURCHASE ORDER FOR A DHA STTR PHASE I, PROPOSAL NO. H23C-001-0042, TITLED, \"DEVELOPMENT OF ANTI-GLYCAN ANTIBODIES AGAINST MULTI-DRUG RESISTANT ESKAPE WOUND PATHOGENS\"","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":1,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}